Patents by Inventor Anthony Bart Nesburn

Anthony Bart Nesburn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunotherapy for recurrent HSV infections
    Patent number: 5679348
    Abstract: Immunotherapy for the treatment of Herpes Simplex Virus eye infections is disclosed. The invention involves a local therapeutic or prophylactic vaccine for the eye, comprising one or more recombinant HSV-1 glycoproteins or proteins, specifically gB and gD, in combination with at least one adjuvant to reduce the incidence of primary HSV-1 infection and/or decrease spontaneous HSV-1 ocular shedding which in turn, controls recurrent corneal disease.
    Type: Grant
    Filed: February 3, 1992
    Date of Patent: October 21, 1997
    Assignee: Cedars-Sinai Medical Center
    Inventors: Anthony Bart Nesburn, Steven Lewis Wechsler, Homayon Ghiasi
  • Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
    Patent number: 5672349
    Abstract: A process for obtaining Herpes Simplex virus type 1 (HSV-1) glycoprotein I (gI) from cells which have been infected or transformed with a recombinant Baculovirus is disclosed. The gI produced is then isolated and purified for use in immunotherapy against HSV infections.
    Type: Grant
    Filed: September 22, 1994
    Date of Patent: September 30, 1997
    Assignee: Cedars Sinai Medical Center
    Inventors: Anthony Bart Nesburn, Steven Lewis Wechsler, Homayon Ghiasi